Galderma, Supernus Sue Impax Over Rosacea Treatment
Galderma Laboratories Inc. and Supernus Pharmaceuticals Inc. hit generic drug maker Impax Laboratories Inc. with a patent infringement suit Thursday in Delaware over Impax's bid for regulatory approval to market its...To view the full article, register now.
Already a subscriber? Click here to view full article